Trials / Recruiting
RecruitingNCT04945369
Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".
Follow-up During the Peripubertal Period of Preterm Children (Under 35 Weeks of Amenorrhea) Included in the "EPIPOD" Protocol : Evaluation of Insulin Resistance
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (estimated)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 8 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | clinical and biological measurements and questionnaires | Blood and urinary samples collection for evaluation of insulin resistance and of renal function analysis. Assessment of body composition by BOP-POD and by impedancemetry. Assessment of pulse wave by popmetre. Assessment of physical activity by accelerometer and by questionnaire Questionnaires for analysis of eating behaviour |
Timeline
- Start date
- 2022-02-02
- Primary completion
- 2028-02-02
- Completion
- 2028-02-02
- First posted
- 2021-06-30
- Last updated
- 2025-11-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04945369. Inclusion in this directory is not an endorsement.